BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20699106)

  • 21. [Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment].
    Noda Y; Nabeshima T
    Yakugaku Zasshi; 2000 Aug; 120(8):677-82. PubMed ID: 10946617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
    Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
    Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin and dopamine interactions in psychosis prevention.
    Richtand NM; McNamara RK
    Prog Brain Res; 2008; 172():141-53. PubMed ID: 18772031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.
    Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T
    Neuropharmacology; 2007 Mar; 52(4):1179-87. PubMed ID: 17313962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.
    Grayson B; Idris NF; Neill JC
    Behav Brain Res; 2007 Nov; 184(1):31-8. PubMed ID: 17675172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotine-antipsychotic drug interactions and attentional performance in female rats.
    Rezvani AH; Levin ED
    Eur J Pharmacol; 2004 Feb; 486(2):175-82. PubMed ID: 14975706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic administration of risperidone to healthy rats: a behavioural and morphological study.
    Castellano O; Moscoso A; Riolobos AS; Carro J; Arji M; Molina V; López DE; Sancho C
    Behav Brain Res; 2009 Dec; 205(2):488-98. PubMed ID: 19665494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase inhibitors--are they potential neuroleptic drugs?
    Becker A; Grecksch G
    Behav Brain Res; 2008 Jan; 186(2):155-60. PubMed ID: 17854922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats.
    Feifel D; Melendez G; Priebe K; Shilling PD
    Behav Brain Res; 2007 Aug; 181(2):278-86. PubMed ID: 17559953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment.
    Qiao H; Noda Y; Kamei H; Nagai T; Furukawa H; Miura H; Kayukawa Y; Ohta T; Nabeshima T
    Neuroreport; 2001 Jan; 12(1):11-5. PubMed ID: 11201068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological interaction of Galphimia glauca extract and natural galphimines with Ketamine and Haloperidol on different behavioral tests.
    Santillán-Urquiza MA; Herrera-Ruiz M; Zamilpa A; Jiménez-Ferrer E; Román-Ramos R; Tortoriello J
    Biomed Pharmacother; 2018 Jul; 103():879-888. PubMed ID: 29710504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic activity of standardized Bacopa extract against ketamine-induced experimental psychosis in mice: Evidence for the involvement of dopaminergic, serotonergic, and cholinergic systems.
    Chatterjee M; Verma R; Kumari R; Singh S; Verma AK; Dwivedi AK; Palit G
    Pharm Biol; 2015; 53(12):1850-60. PubMed ID: 25856700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia.
    Meyer U; Spoerri E; Yee BK; Schwarz MJ; Feldon J
    Schizophr Bull; 2010 May; 36(3):607-23. PubMed ID: 18845557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.
    Celikyurt IK; Kayir H; Ulak G; Erden FB; Ulusoy GK; Uzbay TI
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):528-36. PubMed ID: 21168466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the antipsychotic potential of Panax quinquefolium in ketamine induced experimental psychosis model in mice.
    Chatterjee M; Singh S; Kumari R; Verma AK; Palit G
    Neurochem Res; 2012 Apr; 37(4):759-70. PubMed ID: 22189635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic administration of risperidone in a rat model of schizophrenia: a behavioural, morphological and molecular study.
    Castellano O; Arji M; Sancho C; Carro J; Riolobos AS; Molina V; Gómez-Nieto R; de Anchieta de Castro E Horta J; Herrero-Turrión MJ; López DE
    Behav Brain Res; 2013 Apr; 242():178-90. PubMed ID: 23291154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
    Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
    Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
    Russig H; Murphy CA; Feldon J
    Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
    Wadenberg ML; Fjällström AK; Federley M; Persson P; Stenqvist P
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):644-54. PubMed ID: 20701827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into pharmacological profile of LASSBio-579, a multi-target N-phenylpiperazine derivative active on animal models of schizophrenia.
    Neves G; Antonio CB; Betti AH; Pranke MA; Fraga CA; Barreiro EJ; Noël F; Rates SM
    Behav Brain Res; 2013 Jan; 237():86-95. PubMed ID: 23000351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.